Radiation/nuclear medical countermeasure (MCM) product development support services. Task order e-1, formulation of 3,4,3-LI(1,2-hopo)

Ended Awarded Last action

Contract number
HHSN27200003
Awardee
Awarding agency
Obligated
$715,634

Award facts

Opportunity
Contract value 100% obligated
$715,633.86 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Menlo Park, CA 94025, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00015 $0
Other Administrative Action P00014 $0
Other Administrative Action P00013 $0
Funding Only Action P00012 -$18,859
Other Administrative Action P00011 $0
Other Administrative Action P00010 $0
Funding Only Action P00009 $77,853
Other Administrative Action P00008 · To revise article b.3. Advance understandings, paragraph b.1., subcontracts to extend the period of performance of the lbnl subcontract through june 30, 2020. $0
Funding Only Action P00007 · To obligate additional funds and extend the POP of subk. $23,180
Other Administrative Action 6 $0
Other Administrative Action 5 $0
Funding Only Action 4 $49,157
Other Administrative Action 3 $0
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $584,303
Show all 16

About this award

Written by GovTribe AI ·

This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS), to SRI International, a non-profit research and development institute. The contract, valued at $715,633.86, is for radiation/nuclear medical countermeasure (MCM) product development support services, specifically the formulation of 3,4,3-Li(1,2-HOPO). This contract is not a set-aside and is part of a larger program for MCM product development support services. The prime contractor, SRI International, has subsequently awarded a sub-contract to Formurex Inc., a for-profit organization, to perform additional stability testing and analytical method development work in support of the overall contract. SRI International has extensive experience conducting biomedical research and development for federal agencies like HHS and the Department of Defense through both contracts and grants.

Quick answers

Who was awarded contract HHSN27200003?

HHSN27200003 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 1, 2016.

How much is contract HHSN27200003 worth?

The government has obligated $715,634 on HHSN27200003.

Is contract HHSN27200003 an order under another contract?

Yes. HHSN27200003 is a delivery order under HHSN272201500013I, an indefinite delivery contract.

Was contract HHSN27200003 competed?

The extent of competition for HHSN27200003 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login